BioMed Research International

BioMed Research International / 2018 / Article

Research Article | Open Access

Volume 2018 |Article ID 6796271 |

Hui Zhang, Khalid Mehmood, Xiong Jiang, Wangyuan Yao, Mujahid Iqbal, Kun Li, Xiaole Tong, Lei Wang, Meng Wang, Lihong Zhang, Fazul Nabi, Mujeeb Ur Rehman, Jiakui Li, "Effect of Icariin on Tibial Dyschondroplasia Incidence and Tibial Characteristics by Regulating P2RX7 in Chickens", BioMed Research International, vol. 2018, Article ID 6796271, 11 pages, 2018.

Effect of Icariin on Tibial Dyschondroplasia Incidence and Tibial Characteristics by Regulating P2RX7 in Chickens

Academic Editor: Vasiliki Galani
Received13 Sep 2017
Accepted13 Feb 2018
Published20 Mar 2018


Tibial dyschondroplasia (TD) is a disease of rapid growing chickens that occurs in many avian species; it is characterized by nonvascular and nonmineralized growth plates, along with tibia bone deformation and lameness. Icariin is widely used to treat bone diseases in humans, but no report is available regarding the effectiveness of icariin against avian TD. Therefore, this study was designed to determine its effect against TD. For this purpose, a total of 180 broiler chicks were distributed into three groups including control, TD, and icariin group. Control group was given a standard normal diet, while TD and icariin groups received normal standard diet containing 50 mg/kg thiram to induce TD from days 3 to 7 after hatch. After the induction of TD, the chicks of icariin group were fed with standard normal diet by adding 10 mg/kg icariin in water. Then morphological and production parameters analysis of tibial bone indicators, physiological index changes, and gene expression were examined. The results showed that icariin administration not only decreased the mortality but also mitigated the lameness and promoted the angiogenesis, which diminished the TD lesion and significantly increased the expression of P2RX7 () in TD affected thiram induced chicks. In conclusion, present findings suggest that icariin has a significant role in promoting the recovery of chicken growth plates affected by TD via regulating the P2RX7. Our findings reveal a new target for clinical treatment and prevention of TD in broiler chickens.

1. Introduction

Tibial dyschondroplasia (TD) is a tibiotarsal bone disorder which is linked with rapidly growing avian species, especially broilers [1] and turkeys [2]. It is characterized by dull white nonvascularized and nonmineralized lesion from the epiphyseal growth plate (GP) to the proximal tibiotarsal bone. TD is attributed to abnormal differentiation of chondrocytes which ultimately leads to overt locomotion problem [35]. It was first described in turkeys in 1978, and a recent statistics showed that TD was almost 30% of the bone disorders in chickens and turkeys that caused enormous economic losses and animal welfare problem [6]. TD is an important disease of poultry industry, which leads to leg problem by disturbing the proximal growth plate of the tibia bone [7]. However, there is no systematic study to describe the mechanisms leading to TD development. Previous research indicates that the epiphyseal growth plate chondrocytes show continuous cell proliferation, hypertrophy, remodeling, and cell removal in early phase of the growth [8]. The development of GP is constitutive of different regions, germinal, proliferating, prehypertrophic, and hypertrophic zone, which accommodate chondrocytes with discrete morphology along with deeply penetrating metaphysical trabecular bone and blood vessels [9, 10].

Although the exact pathogenesis of TD is still not clear, many researchers have speculated the possible pathogenesis and treatment of this disorder [1013]. The recent studies showed that the nutrition, selective breeding, and rearing environment affect the incidence of TD [3, 12, 14]. However, limited studies have shown the systematic approach to investigate the changing rule of bone remodeling in TD chickens.

The mechanism of bone remodeling is to maintain the skeleton and replacement of damaged bone [15]. The pathway of bone remodeling is the mechanical stimuli, cellular responses, and mechanotransduction, but previous studies have shown that the nucleotide discharge and successive P2 receptor activation also play an important role in this pathway [1618]. More recently, disruption of gene encoding P2X7 receptor in mice suggested its role in the regulation of bone formation and resorption [18, 19]. The P2X7 nucleotide receptor (P2X7R) is expressed in bone and plays important role in bone metabolism [20]. Mice with a null mutation of the P2X7R were shown to have a reduced total bone mineral content, reduced periosteal bone formation, and increased trabecular bone resorption [19, 21].

Icariin is a natural flavonoid glycoside isolated from some species of plants belonging to the genus Epimedium [22]. Traditionally, it is widely recorded for the treatment of erectile dysfunction in China [22, 23]. However, much attention has been given towards its potential to treat bone problems, cardiovascular, which are demonstrated as a potential osteogenic compound for bone repairmen and bone formation. Most interestingly, it has been reported that bone regeneration was significantly enhanced after the implantation of icariin clinically [24, 25].

Previous reports suggest that icariin has efficient chondroprotective activities [26], and it can prevent degradation of bone in arthritis by reducing chondrocytes destruction [27]. Zhang et al. [28] stated that icariin can induce chondrogenesis by promoting gene expression of chondrocytes and extracellular matrix synthesis. So, we hypothesized that icariin could prevent TD by improving the bone formation and repairing the affected GPs. Thus, the aim of the present study was to investigate the possibility of icariin action against thiram induced TD in chickens via regulating the expression of P2XR7.

2. Materials and Methods

2.1. Chick’s Management and Experimental Plan

A total of 180-day-old broiler chickens (Arbor Acres) of weighing 48 ± 6 g were brought from a commercial hatchery. All groups were offered ad libitum regular diet as suggested by the National Research Council [29]. The experiments were conducted after the approval of Institutional Animal Welfare and Research, Ethics Committee of Huazhong Agricultural University, Wuhan, China.

One hundred and eighty chickens were equally divided into control group, TD group, and icariin group. TD and icariin group were given standard normal along with the addition of thiram 50 mg/kg of feed from day 3 after hatch to induce TD. After induction of TD (on day 8) the icariin group was separated and fed with standard normal diet along with addition of 10 mg/kg/day icariin through drinking water until the end of the experiment. From day 8, the TD group was offered standard normal feed just like control group.

2.2. Morphological and Production Parameters Analysis and Sample Collection

The chicken groups were raised for 18 days and the number of morbidity, mortality, and lame birds (walking abilities and the period they were able to remain standing) was recorded in each group on daily basis. During the experimental period, 10 chicks were sacrificed by cervical dislocation randomly on days 7, 10, 14, and 18 from each group. After euthanizing, the tibia bones were measured for morphological examination including length, width, size of tibial GP, and weight by Digital Calipers and electronic balance, respectively. The TD score and severity of TD were determined according to Pines et al. [6] and Simsa et al. [2]. Briefly, TD score 0 = normal growth plate; 1 = recognizable cartilage plaque; 2 = 20% cartilage plaque which was covered up in the longitudinal section of tibia bone; 3 = 50% cartilage plaque which was covered up in the longitudinal section of tibia bone; and 4 = 80% cartilage plaque was covered up in the longitudinal section of tibia bone. The average TD score was calculated for each group by summing the total score for all the chick legs in a group and divided by total number of legs. After that, some tibia bones were fixed in 4% paraformaldehyde and other tibia bones were immediately frozen in liquid nitrogen and stored at −70°C for further analysis.

2.3. Hematoxylin & Eosin (H&E) Staining and Immunohistochemistry (IHC)

The fixed (4% paraformaldehyde) tibia bone samples were processed according to Mehmood et al. [30]. The IHC was measured according to previous studies as described by Herzog et al. [31]; the slides were washed in PBS and peroxidase blocking solution (Boster, Wuhan). The slides were incubated with primary antibody against P2RX7 (ABclonal technology, Wuhan, China) with 1 : 2000 dilutions at 4°C overnight. After that they washed with PBS and incubated at 37°C for one and half hour with the horseradish peroxidase-conjugated anti-rabbit secondary antibodies. The immunolabeled slides were observed under the microscope and at last the primary antibodies were removed from negative control.

2.4. Quantitative Real-Time Polymerase Chain Reaction (RT-qPCR)

Total RNA of the tibial GP tissues was extracted from each group of chickens using Trizol reagent (Invitrogen, Carlsbad, California, USA), while RNA was transcribed into cDNA according to our previous study [32]. RNA was transcribed into cDNA by using first-strand reverse transcription cDNA kit (Tian Gen, China), according to manufacturer’s instructions. Following P2RX7 primer F, ACTTGTGTCCTATGTCGATAAGC and R: AGCAGGTGCGAGGATCATA were used. The RT-qPCR was performed in quadruplex with Step One-Plus™ Real-Time PCR System (Applied Biosystems) for a total volume of 20 μl according to our previous study [32]. All the reaction mixture was normalized against GAPDH gene, while relative quantification of genes was measured using delta Ct () method [33].

2.5. Western Blot Analysis

Growth plate of individual tissues was processed according to our previous study [34]. Briefly, after incubating with blocking buffer the membrane was treated with primary antibody (rabbit monoclonal anti-P2RX7, Abcam, 1 : 1000 dilution) at 4°C overnight and then washed 3 times and incubated with secondary antibody. After washing, the images were captured with an imaging system (UVP, Upland, CA, USA).

2.6. Statistical Analysis

The results obtained were analyzed by two way ANOVA and student -test to compare the differences between mean values of different groups. The analyses were performed by using SPSS 19.0 software and data were presented as means ± SEM (standard error of means). was used for statistically significant.

3. Results

3.1. The Mortality Rate Evaluation among Control, TD, and Icariin Groups

The mortality was evaluated from day 3 to day 18 in each group. The results showed that mortality rate on day 3 and day 10 was much increased in TD group as compared to control group and then subsequently started to reduce. The mortality rate decreased and TD was restored after removing the thiram from day 14 to day 18. However, in icariin group, the mortality rate of chickens decreased as compared to TD group, as shown in Figure 1.

3.2. Icariin Prevented the TD in Chickens

The visual examination indicated the depression and poor body condition in thiram induced TD chickens along with weakness, lameness, and feeding difficulties. As compared with the TD affected chickens, the icariin treatment group regained their ability to stand and walk properly (Figure 2(a)). The continuous administration of icariin in drinking water caused a further decrease in the signs of lameness, and almost all birds reverted to the control level. The morphometry of tibia bone indicated that icariin administration resulted in a significant reduction in growth plate width as compared to thiram fed TD group (Figure 2(b)). The correlation of average score showed that the icariin administration reduced the average TD score in chickens.

3.3. Icariin Promoted the Vascularization and Inhibited the Formation of TD Lesion

To check whether the icariin can promote the vascularization in GP and inhibit the formation of TD lesion, we analyzed the overall tibia bone parameters. The results of tibial parameters revealed that the average value of tibia (TB) weight/chicken (C) weight was 0.0092 in control group, while it was higher in TD group as compared with control group. However, with the usage of icariin, the value became lower (Figure 3(a)). The TB width/TB weight of GP was down in control group as compared with TD group, while icariin treatment group showed very near value to the control group (Figure 3(b)). The TB length/TB weight was decreased from day 7 to day 18 with no significant changes among all the three groups (Figure 3(c)).

3.4. TD Score Assay

Thiram induced TD in almost 90% chickens in TD group and tibia showed severe TD lesions (scores 3 and 4), while average TD score was higher compared to control group. In control group, tibia was almost normal phenotypically and average TD score was also less. However, icariin group showed that chicken had restored the TD pathogenesis and more than 50% chickens were found healthy. The average TD score significantly decreased (<2.0) in icariin group on day 18 (Figure 4).

3.5. Histological Examination of Tibial Growth Plates

In order to observe the histopathology micrograph of blood version and cell morphology in tibia bone, H&E staining was performed in control group, TD group, and icariin treatment group. The results showed that the normal GP exhibits regular columns and cells surrounded by large number of blood vessels in proliferative and hypertrophic zone (Figure 5(a)). However, in TD group, a large number of cell death, empty cartilages, disordered arrangements of chondrocytes, and degradation were found in proliferative and hypertrophic zones of growth plate. Calcified area of the GP was shrinked with vascular banding and hypertrophy of cartilage cell. In addition, the vascular necrosis and bone resorption were slow in TD afflicted group (Figure 5(b)). However, icariin restored angiogenesis in the proliferative and hypertrophic zones of growth plate (Figure 5).

3.6. Icariin Promoted the Trabecular Bone and Blood Version Formation in TD Affected Chickens

The results of H&E staining revealed that TD affected chickens had decreased blood version numbers assay (BV.N) and trabecular bone volume (BV/TV) in tibia. However, increased blood version numbers assay (Figure 6) and trabecular bone volume (Figure 7) were found in tibia after icariin administration.

3.7. Immunohistochemical Localization of P2RX7 in Tibial Hypertrophic Zone

The expression of P2RX7 antibody in the tibia hypertrophic zone was evaluated via immunohistochemistry. The results showed that few numbers of cells were expressed in P2RX7 TD-effected chickens when compared with the control and icariin groups (Figure 8).

3.8. The P2RX7 Gene Level and Protein Expression in Growth Plates

The expression profile of P2RX7 gene involved in the growth plates of chicken indicated that the mRNA expression of P2RX7 was significantly decreased () in TD group as compared to control group. However, icariin administration significantly upregulated the P2RX7 gene expression from day 10 to day 18 (Figure 9(a)). The protein level was assessed by western blotting analysis in tibia bone on days 7, 10, 14, and 18. Results revealed that P2RX7 expression was significantly downregulated () in TD group on days 7, 10, 14, and 18 as compared to control group (). But, the level of P2RX7 protein was obviously increased with the administration of icariin on day 14 and day 18 (Figure 9(b)).

4. Discussion

Icariin has been widely reported as a potential osteogenic compound for bone repair because it can promote the osteoblast proliferation and osteogenic differentiation [35, 36]. Previous studies have shown that icariin can induce osteogenic differentiation and can protect against osteolysis and inflammation. Therefore, it is widely used in the treatment of bone diseases [3739]. In this study, we have used the icariin for the treatment of TD, in order to find a new target medicine for the prevention of TD in broiler chickens. Normal growth plate development entails cartilage vascularization and mineralization followed by osteogenesis. But tibial dyschondroplasia is a bone abnormality and characterized by endochondral ossification suffocate, tibial metaphyseal cartilage cell proliferation, avascular, nonmineralized, and white cartilaginous opaque mass in GP [4, 39]. Previous studies show that clinical features of TD include gait abnormality, inability to stand and walk properly, and sometime even death [3, 39, 40]. Our research confirmed the findings of previous reports, like reducing body weight gain and increasing mortality in TD affected chickens. However, after administering the icariin, the chickens become healthy and mortality was reduced significantly.

In order to further study the effect of icariin on pathological changes in TD affected chickens. Our study showed that bone development in chickens starts from immature cartilage cells of static zoon, then proliferative zone, hypertrophy stage and gradually mature, angiogenesis, calcification, and finally bone tissue in proximal growth plate. The vascularization is rich in cartilage zone and cartilage cells are clear with nucleus in the centre. The cell volume is similar to less intercellular substance, and trabecular bone is in mature chondrocytes cartilage capsule during normal growth of chicken. Meanwhile, the excessive growth was found in immature cartilage cells arranged tightly; some nucleus pycnosis and apoptosis were found in severe TD lesions. However, after the treatment of icariin, the histopathology of bone in TD affected chickens approach the normal chickens. Huang et al. [41] stated that hypoxia can enhance the vascularization in the proximal growth plate for bone development. Wang et al. [42] studied that chondrogenesis is regulated by many factors while hypoxia is main factor for the development and regeneration of cartilage because it regulates chondrocytes cell proliferation. Icariin can enhance hypoxia reactive element luciferase activity and play important role in chondrogenesis [42]. Previous studies have shown that the TD affected GP which contains minerals including Na, Mg, P, Cl, S, and Ca just like normal GP and undergoes cell proliferation at the same rate [43, 44]. Moreover, metabolic acidosis, impairment of vascularization, and growth rate have been reported to influence the incidence of TD [10, 45, 46]. However, recently research on TD has found that TD is related to the bone remodeling and reformation.

The P2RX7 is demonstrated to be expressed by major bone cell types, including osteoblasts [46, 47], osteoclasts [48, 49], and osteocytes [50] and the overall effect of a functional P2RX7 on bone metabolism [16]. Some studies also showed that activation of the P2RX7 could inhibit resorption of bone and can stimulate the differentiation of osteoblasts with enhancement of mineralization [51]. Furthermore, P2RX7 plays an essential role in calcium signaling from osteoblasts to osteoclasts in response to mechanical stimulation [52]. In our study, we found significantly decreased level of P2RX7 in TD chickens as compared with normal on day 7 to day 18. Whereas, with the use of icariin, the expression of P2RX7 gene becomes upregulated as compared with TD chickens, the macroscopic observation and pathology examination also confirmed our results.

Chinese traditional medicine and natural products have paid attention to the general public. Present study has found that icariin can activate the P2RX7, which inhibit the resorption of the bone and stimulate the differentiation of osteoblasts, along with the enhancement of mineralization in GP to prevent the TD incidence and its characteristics in broiler chickens. This is the first study that explains the effect of icariin in tibial dyschondroplasia incidence, tibial angiogenesis, and its characteristics via regulating the P2RX7 in chickens.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Hui Zhang and Khalid Mehmood made equal contributions in this study.


The study was supported by National Key Research and Development Program of China (Project no. 2017YFD0502200) and the National Natural Science Foundation of China (no. 31460682).


  1. N. C. Rath, M. P. Richards, W. E. Huff, G. R. Huff, and J. M. Balog, “Changes in the tibial growth plates of chickens with thiram-induced dyschondroplasia,” Journal of Comparative Pathology, vol. 133, no. 1, pp. 41–52, 2005. View at: Publisher Site | Google Scholar
  2. S. Simsa, A. Hasdai, H. Dan, and E. M. Ornan, “Induction of tibial dyschondroplasia in turkeys by tetramethylthiuram disulfide (Thiram),” Poultry Science, vol. 86, no. 8, pp. 1766–1771, 2007. View at: Publisher Site | Google Scholar
  3. D. Jefferies, B. Houston, D. Lester et al., “Expression patterns of chondrocyte genes cloned by differential display in tibial dyschondroplasia,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1501, no. 2-3, pp. 180–188, 2000. View at: Publisher Site | Google Scholar
  4. M. Shahzad, J. Liu, J. Gao et al., “Hsp-90 inhibitor geldanamycin attenuates liver oxidative stress and toxicity in thiram-induced tibial dyschondroplasia,” Pakistan Veterinary Journal, vol. 34, no. 4, pp. 545–547, 2014. View at: Google Scholar
  5. W. X. Tian, J. Li, P. Qin et al., “Screening of differentially expressed genes in the growth plate of broiler chickens with tibialdyschondroplasia by microarray analysis,” BMC Genomics, vol. 14, p. 276, 2013. View at: Google Scholar
  6. M. Pines, A. Hasdai, and E. Monsonego-Ornan, “Tibial dyschondroplasia - Tools, new insights and future prospects,” World's Poultry Science Journal, vol. 61, no. 2, pp. 285–297, 2005. View at: Publisher Site | Google Scholar
  7. E. Kaukonen, M. Norring, and A. Valros, “Perches and elevated platforms in commercial broiler farms: use and effect on walking ability, incidence of tibialdyschondroplasia and bone mineral content,” Animal, vol. 11, no. 5, pp. 1–8, 2016. View at: Google Scholar
  8. K. Ohyama, C. Farquharson, C. C. Whitehead, and I. M. Shapiro, “Further observations on programmed cell death in the epiphyseal growth plate: Comparison of normal and dyschondroplastic epiphyses,” Journal of Bone and Mineral Research, vol. 12, no. 10, pp. 1647–1656, 1997. View at: Publisher Site | Google Scholar
  9. S.-H. Lee, X. Che, J.-H. Jeong et al., “Runx2 protein stabilizes hypoxia-inducible factor-1α through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes,” The Journal of Biological Chemistry, vol. 287, no. 18, pp. 14760–14771, 2012. View at: Publisher Site | Google Scholar
  10. R. M. Leach Jr. and E. Monsonego-Ornan, “Tibial dyschondroplasia 40 years later,” Poultry Science, vol. 86, no. 10, pp. 2053–2058, 2007. View at: Publisher Site | Google Scholar
  11. H. Dan, S. Simsa-Maziel, A. Hisdai, D. Sela-Donenfeld, and E. Monsonego Ornan, “Expression of matrix metalloproteinases during impairment and recovery of the avian growth plate,” Journal of Animal Science, vol. 87, no. 11, pp. 3544–3555, 2009. View at: Publisher Site | Google Scholar
  12. M. Shahzad, J. Gao, P. Qin et al., “Expression of Genes Encoding Matrilin-3 and Cyclin-I during the Impairment and Recovery of Chicken Growth Plate in Tibial Dyschondroplasia,” Avian Diseases, vol. 58, no. 3, pp. 468–473, 2014. View at: Publisher Site | Google Scholar
  13. N. C. Rath, W. E. Huff, and G. R. Huff, “Thiram-induced changes in the expression of genes relating to vascularization and tibial dyschondroplasia,” Poultry Science, vol. 86, no. 11, pp. 2390–2395, 2007. View at: Publisher Site | Google Scholar
  14. M. Shahzad, J. Liu, J. Gao et al., “Differential expression of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in avian tibial dyschondroplasia,” Avian Pathology, vol. 44, no. 1, pp. 13–18, 2015. View at: Publisher Site | Google Scholar
  15. F. Xu and J. M. Mcdonald, “Disorders of bone remodeling,” Annual Review of Pathology, vol. 6, no. 1, p. 121, 2011. View at: Google Scholar
  16. M. W. Grol, N. Panupinthu, J. Korcok, S. M. Sims, and S. J. Dixon, “Expression, signaling, and function of P2X7 receptors in bone,” Purinergic Signalling, vol. 5, no. 2, pp. 205–221, 2009. View at: Publisher Site | Google Scholar
  17. D. W. Dempster, J. B. Lian, and S. R. Goldring, “Anatomy and functions of the adult skeleton,” in Primer on the metabolic bone diseases and disorders of mineral metabolism, M. J. Favus, Ed., pp. 7–11, American Society for Bone and Mineral Research, Washington, DC, USA, 6th edition, 2006. View at: Google Scholar
  18. H. Z. Ke, H. Qi, A. F. Weidema et al., “Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption,” Molecular Endocrinology, vol. 17, no. 7, pp. 1356–1367, 2003. View at: Publisher Site | Google Scholar
  19. A. Hoebertz, A. Townsend-Nicholson, R. Glass, G. Burnstock, and T. R. Arnett, “Expression of P2 receptors in bone and cultured bone cells,” Bone, vol. 27, no. 4, pp. 503–510, 2000. View at: Publisher Site | Google Scholar
  20. P. Pelegrin and A. Surprenant, “Pannexin-1 mediates large pore formation and interleukin-1 release by the ATP-gated P2X7 receptor,” EMBO Journal, vol. 25, no. 21, pp. 5071–5082, 2014. View at: Publisher Site | Google Scholar
  21. A. Gartland, K. A. Buckley, W. B. Bowler, and J. A. Gallagher, “Blockade of the Pore-Forming P2X7 Receptor Inhibits Formation of Multinucleated Human Osteoclasts In Vitro,” Calcified Tissue International, vol. 73, no. 4, pp. 361–369, 2003. View at: Publisher Site | Google Scholar
  22. J. K. Schluesener and H. Schluesener, “Plant polyphenols in the treatment of age-associated diseases: Revealing the pleiotropic effects of icariin by network analysis,” Molecular Nutrition & Food Research, vol. 58, no. 1, pp. 49–60, 2014. View at: Publisher Site | Google Scholar
  23. C. Li, Q. Li, Q. Mei, and T. Lu, “Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii,” Life Sciences, vol. 126, pp. 57–68, 2015. View at: Publisher Site | Google Scholar
  24. Z. T. Mo et al., “Icariin attenuates OGD/R-induced autophagy via Bcl-2-dependent cross talk between apoptosis and autophagy in PC12 cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 4343084, pp. 1–6, 2016. View at: Google Scholar
  25. D. Li, T. Yuan, X. Zhang et al., “Icariin: a potential promoting compound for cartilage tissue engineering,” Osteoarthritis and Cartilage, vol. 20, no. 12, pp. 1647–1656, 2012. View at: Publisher Site | Google Scholar
  26. N. Liu, T. Zhang, B. R. Cao et al., “Icariin possesses chondroprotective efficacy in a rat model of dexamethasone-induced cartilage injury through the activation of miR-206 targeting of cathepsin K,” International Journal of Molecular Medicine, vol. 41, no. 2, pp. 1039–1047, 2018. View at: Google Scholar
  27. C. C. Wei, D. Q. Ping, F. T. You, C. Y. Qiang, and C. Tao, “Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis,” Mediators of Inflammation, vol. 2016, p. 9529630, 2016. View at: Publisher Site | Google Scholar
  28. L. Zhang, X. Zhang, K.-F. Li et al., “Icariin promotes extracellular matrix synthesis and gene expression of chondrocytes in vitro,” Phytotherapy Research, vol. 26, no. 9, pp. 1385–1392, 2012. View at: Publisher Site | Google Scholar
  29. International Journal of Molecular Medicine, Nutrient requirements of poultry, National Academy Press, Washington, DC, USA, 9th edition, 2001.
  30. K. Mehmood, H. Zhang, M. K. Iqbal et al., “Tetramethylpyrazine Mitigates Toxicity and Liver Oxidative Stress in Tibial Dyschondroplasia Chickens,” Pakistan Veterinary Journal, vol. 38, no. 1, pp. 76–80, 2018. View at: Google Scholar
  31. A. Herzog, O. Genin, A. Hasdai, D. Shinder, and M. Pines, “Hsp90 and angiogenesis in bone disorders-lessons from the avian growth plate,” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 301, no. 1, pp. 140–147, 2011. View at: Publisher Site | Google Scholar
  32. Z. Chang, H. Zhang, X. Wu et al., “Renal Dose Dopamine Mediates the Level of Aquaporin-2 Water Channel (Aqp2) in Broiler Chickens,” Brazilian Journal of Poultry Science, vol. 19, pp. 387–392, 2017. View at: Google Scholar
  33. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at: Publisher Site | Google Scholar
  34. K. Mehmood, H. Zhang, K. Li et al., “Effect of tetramethylpyrazine on tibial dyschondroplasia incidence, tibial angiogenesis, performance and characteristics via HIF-1α/VEGF signaling pathway in chickens,” Scientific Reports, vol. 8, article no. 2495, no. 1, 2018. View at: Publisher Site | Google Scholar
  35. J. Zhao, S. Ohba, Y. Komiyama, M. Shinkai, U.-I. Chung, and T. Nagamune, “Icariin: A potential osteoinductive compound for bone tissue engineering,” Tissue Engineering Part A, vol. 16, no. 1, pp. 233–243, 2010. View at: Publisher Site | Google Scholar
  36. K. M. Chen, B. F. Ge, H. P. Ma, X. Y. Liu, M. H. Bai, and Y. Wang, “Icariin, a flavonoid from the herb epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells,” Pharmazie, vol. 60, no. 12, p. 939, 2005. View at: Google Scholar
  37. K. Wei, Y. Xu, Z. Zhao et al., “Icariin alters the expression of glucocorticoid receptor, FKBP5 and SGK1 in rat brains following exposure to chronic mild stress,” International Journal of Molecular Medicine, vol. 38, no. 1, pp. 337–344, 2016. View at: Publisher Site | Google Scholar
  38. M. S. Domowicz, M. Cortes, J. G. Henry, and N. B. Schwartz, “Aggrecan modulation of growth plate morphogenesis,” Developmental Biology, vol. 329, no. 2, pp. 242–257, 2009. View at: Publisher Site | Google Scholar
  39. H. Zhang, K. Mehmood, K. Li et al., “Icariin Ameliorate Thiram-Induced Tibial Dyschondroplasia via Regulation of WNT4 and VEGF Expression in Broiler Chickens,” Frontiers in Pharmacology, vol. 9, p. 123, 2018. View at: Publisher Site | Google Scholar
  40. F. Nabi et al., “Gambogic acid inhibits hsp90 expressions in thiram-induced tibialdyschondroplasia,” Pakistan Veterinary Journal, vol. 36, pp. 224-225, 2016. View at: Google Scholar
  41. S.-C. Huang, M. U. Rehman, Y.-F. Lan et al., “Tibial dyschondroplasia is highly associated with suppression of tibial angiogenesis through regulating the HIF-1α/VEGF/VEGFR signaling pathway in chickens,” Scientific Reports, vol. 7, no. 1, article no. 9089, 2017. View at: Publisher Site | Google Scholar
  42. P. Wang, F. Zhang, Q. He et al., “Flavonoid compound icariin activates hypoxia inducible factor-1α in chondrocytes and promotes articular cartilage repair,” PLoS ONE, vol. 11, no. 2, Article ID e0148372, 2016. View at: Publisher Site | Google Scholar
  43. C. C. van Donkelaar, X. J. A. Janssen, and A. M. de Jong, “Distinct developmental changes in the distribution of calcium, phosphorus and sulphur during fetal growth-plate development,” Journal of Anatomy, vol. 210, no. 2, pp. 186–194, 2007. View at: Publisher Site | Google Scholar
  44. S. Omelon, J. Georgiou, Z. J. Henneman et al., “Control of vertebrate skeletal mineralization by polyphosphates,” PLoS ONE, vol. 4, no. 5, Article ID e5634, 2009. View at: Publisher Site | Google Scholar
  45. K. Mehmood, H. Zhang, M. K. Iqbal et al., “In Vitro Effect of Apigenin and Danshen in Tibial Dyschondroplasia Through Inhibition of Heat-Shock Protein 90 and Vascular Endothelial Growth Factor Expressions in Avian Growth Plate Cells,” Avian Diseases, vol. 61, no. 3, pp. 372–377, 2017. View at: Publisher Site | Google Scholar
  46. W. Li, G. Li, Y. Zhang et al., “Role of P2×7 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes,” Experimental Cell Research, vol. 339, no. 2, pp. 367–379, 2015. View at: Publisher Site | Google Scholar
  47. A. Gartland, R. A. Hipskind, J. A. Gallagher, and W. B. Bowler, “Expression of a P2X7 receptor by a subpopulation of human osteoblasts,” Journal of Bone and Mineral Research, vol. 16, no. 5, pp. 846–856, 2001. View at: Publisher Site | Google Scholar
  48. K. A. Buckley, R. A. Hipskind, A. Gartland, W. B. Bowler, and J. A. Gallagher, “Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-κB ligand,” Bone, vol. 31, no. 5, pp. 582–590, 2002. View at: Publisher Site | Google Scholar
  49. N. R. Jorgensen, Z. Henriksen, O. H. Sørensen, E. F. Eriksen, R. Civitelli, and T. H. Steinberg, “Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors,” The Journal of Biological Chemistry, vol. 277, no. 9, pp. 7574–7580, 2002. View at: Publisher Site | Google Scholar
  50. J. Li, D. Liu, H. Z. Ke, R. L. Duncan, and C. H. Turner, “The P2X7 nucleotide receptor mediates skeletal mechanotransduction,” The Journal of Biological Chemistry, vol. 280, no. 52, pp. 42952–42959, 2005. View at: Publisher Site | Google Scholar
  51. P. Nattapon, J. T. Rogers, Z. Lin, S. F. L. Pastor, P. Fred, S. M. Sims et al., “P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis,” Journal of Cell Biology, vol. 181, no. 5, p. 859, 2008. View at: Google Scholar
  52. A. Wesselius, M. J. L. Bours, Z. Henriksen et al., “Association of P2X7 receptor polymorphisms with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients,” Osteoporosis International, vol. 24, no. 4, pp. 1235–1246, 2013. View at: Publisher Site | Google Scholar

Copyright © 2018 Hui Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles